Xenon Pharmaceuticals Inc
€46.37
EUR
Last updated on --.
24h volume1.51M
24h highest51.5116 EUR
24h lowest45.8005 EUR
24h Price movement-0.35%
XENE recent prices
24 Hours
-0.35%-€0.16325
30 days
-0.52%-€0.24058
60 days
-0.61%-€0.28354
90 days
+20.17%+€7.784
Key data
Previous close46.5429 EUR
Market cap4.54B EUR
Volume1.51M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-3.4024 EUR
Net income (FY)-329.22M EUR
Revenue (FY)0.00 EUR
Last report date7 May 2026
About Xenon Pharmaceuticals Inc
HeadquartersBURNABY
Employees (FY)370.00
Revenue per employee (FY)0.00 EUR
Net income per employee (FY)-889.77K EUR
Listed onNasdaq
XENE conversion tables
 |  |
|---|---|
| 0.5 XENE | 23.18 EUR |
| 1 XENE | 46.37 EUR |
| 5 XENE | 231.89 EUR |
| 10 XENE | 463.79 EUR |
| |
|---|---|
| 0.5 EUR | 0.010781 XENE |
| 1 EUR | 0.021561 XENE |
| 5 EUR | 0.10781 XENE |
| 10 EUR | 0.21561 XENE |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
XENE is trading at €46.37, -0.35% over the last 24 hours. Track live moves on the price chart at the top of this page.
The XENE stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. XENE is currently trading at €46.37, -0.35% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on XENE price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. XENE's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from XENE; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against XENE's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Xenon Pharmaceuticals Inc's market cap is currently 4.54B EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume1.51M
24h highest51.5116 EUR
24h lowest45.8005 EUR
24h Price movement-0.35%
Start trade with XENE Perpetual
Sign up to trade